CBST

Cubist Pharmaceuticals, Inc. Press Releases

$100.3
*  
0.01
0.01%
Get CBST Alerts
*Delayed - data as of Dec. 26, 2014  -  Find a broker to begin trading CBST now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Cubist Announces FDA Approval of New Antibiotic ZERBAXA™ (Ceftolozane/Tazobactam) for Complicated Urinary Tract and Complicated Intra-abdominal Infections
12/19/2014 6:08:00 PM - Business Wire
▼-0.20 % Price Change since this news event. The Volume Ratio is 2.91.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Merck Begins Tender Offer to Acquire Cubist
12/19/2014 8:00:00 AM - Business Wire


CUBIST PHARMACEUTICALS INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Cubist Pharmaceuticals, Inc. Over the Proposed Sale of the Company to Merck & Co. Inc. - CBST
12/12/2014 8:30:00 PM - PR Newswire
▲4.15 % Price Change since this news event. The Volume Ratio is 0.17.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


CBST SHAREHOLDER ALERT: The Law Offices of Vincent Wong Launches Investigation of the Board of Directors of Cubist Pharmaceuticals, Inc. in Connection With the Fairness of the Sale of the Company to Merck & Co.
12/12/2014 10:19:00 AM - Business Wire
▲3.99 % Price Change since this news event. The Volume Ratio is 0.36.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


CUBIST PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
12/11/2014 2:22:00 PM - Business Wire
▲3.97 % Price Change since this news event. The Volume Ratio is 0.31.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Lifshitz & Miller Law Firm Announces Investigation of Actuate Corporation, Albany Molecular Research Inc., Conn's, Inc., Cubist Pharmaceuticals, Inc., Hawaiian Electric Industries, Inc., and Heritage Financial Group, Inc.
12/11/2014 12:45:00 PM - PR Newswire


Ryan & Maniskas, LLP Announces Investigation of Cubist Pharmaceuticals Inc.
12/9/2014 10:53:00 AM - PR Newswire
▲3.83 % Price Change since this news event. The Volume Ratio is 4.39.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Harwood Feffer LLP Announces Investigation of Cubist Pharmaceuticals Inc.
12/8/2014 8:00:00 PM - PR Newswire
▲0.91 % Price Change since this news event. The Volume Ratio is 3.89.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Cubist Comments on CUBICIN Patent Litigation
12/8/2014 6:52:00 PM - Business Wire
▲1.11 % Price Change since this news event. The Volume Ratio is 3.9.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


CUBIST PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Merck & Co., Inc.
12/8/2014 11:57:00 AM - Business Wire
▼-0.46 % Price Change since this news event. The Volume Ratio is 34.84.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


CUBIST PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
12/8/2014 10:45:00 AM - PR Newswire


CUBIST PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
12/8/2014 10:45:00 AM - PR Newswire
▼-0.46 % Price Change since this news event. The Volume Ratio is 36.51.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Block & Leviton LLP Investigates Cubist Pharmaceuticals Inc. for Possible Breaches of Fiduciary Duty in Connection with Its Proposed Acquisition by Merck & Co.
12/8/2014 10:32:00 AM - PR Newswire
▼-0.43 % Price Change since this news event. The Volume Ratio is 38.13.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Cubist Pharmaceuticals, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Merck
12/8/2014 10:30:00 AM - PR Newswire
▼-0.37 % Price Change since this news event. The Volume Ratio is 38.21.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Merck to Acquire Cubist Pharmaceuticals for $102 Per Share in Cash
12/8/2014 7:00:00 AM - Business Wire


ProQR Therapeutics Announces Results for the Third Quarter of 2014
11/24/2014 7:00:00 AM - GlobeNewswire


European Antibiotic Awareness Day Highlights Need for Urgent Action
11/17/2014 1:00:00 AM - Business Wire


Cubist Names Dr. Patrick Vink Chief Operating Officer
11/5/2014 7:30:00 AM - Business Wire
▲38.31 % Price Change since this news event. The Volume Ratio is 0.78.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Cubist to Present at Jefferies 2014 Healthcare Conference
11/3/2014 9:00:00 AM - Business Wire
▲38.75 % Price Change since this news event. The Volume Ratio is 1.05.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Cubist Reports Third Quarter 2014 Financial Results
10/21/2014 4:00:00 PM - Business Wire
▲50.10 % Price Change since this news event. The Volume Ratio is 1.35.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Cubist Pharmaceuticals Names Robert J. Perez Chief Executive Officer
10/20/2014 7:30:00 AM - Business Wire
▲50.78 % Price Change since this news event. The Volume Ratio is 1.3.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Cubist to Announce Third Quarter 2014 Financial Results on Tuesday, October 21, 2014
10/14/2014 9:00:00 AM - Business Wire
▲64.83 % Price Change since this news event. The Volume Ratio is 1.61.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Cubist to Present New Data from Study of fidaxomicin in Children with Clostridium Difficile-Associated Diarrhea at IDWeek 2014
10/8/2014 8:30:00 AM - Business Wire


Cubist to Present New Data on Antibiotics Portfolio at IDWeek 2014
9/30/2014 8:30:00 AM - Business Wire